Thoratec Corporation (Nasdaq: THOR) has filed a PMA (Pre-Market Approval) supplement with the FDA seeking to add the intended ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE